 | • レポートコード：MRC2-11QY14039 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、147ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は高分子医薬品コンジュゲートのグローバル市場について調査・分析したレポートです。種類別（ポリマー-Doxコンジュゲート、ポリマー-パクリタキセルコンジュゲート、ポリマー-カンプトテシンコンジュゲート、ポリマー-プラチナコンジュゲート）市場規模、用途別（がん治療、ロイクミア、肝炎、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別高分子医薬品コンジュゲートの競争状況、市場シェア ・世界の高分子医薬品コンジュゲート市場：種類別市場規模 2015年-2020年（ポリマー-Doxコンジュゲート、ポリマー-パクリタキセルコンジュゲート、ポリマー-カンプトテシンコンジュゲート、ポリマー-プラチナコンジュゲート） ・世界の高分子医薬品コンジュゲート市場：種類別市場規模予測 2021年-2026年（ポリマー-Doxコンジュゲート、ポリマー-パクリタキセルコンジュゲート、ポリマー-カンプトテシンコンジュゲート、ポリマー-プラチナコンジュゲート） ・世界の高分子医薬品コンジュゲート市場：用途別市場規模 2015年-2020年（がん治療、ロイクミア、肝炎、その他） ・世界の高分子医薬品コンジュゲート市場：用途別市場規模予測 2021年-2026年（がん治療、ロイクミア、肝炎、その他） ・北米の高分子医薬品コンジュゲート市場分析：米国、カナダ ・ヨーロッパの高分子医薬品コンジュゲート市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの高分子医薬品コンジュゲート市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の高分子医薬品コンジュゲート市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの高分子医薬品コンジュゲート市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：3S Bio、Abeona Therapeutics、Abramson Cancer Center、Access Pharmaceuticals、Adama、Eyetech、Ferring、Flamel Technologies、Genentech、GlaxoSmithKline、Gowan、Gynecologic Oncology Group Foundation、JenKem Technology、Landec、Lipotek ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Polymer Drug Conjugates Market
The global Polymer Drug Conjugates market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Polymer Drug Conjugates Scope and Market Size
Polymer Drug Conjugates market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Polymer Drug Conjugates market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Polymer Drug Conjugates market is segmented into
Polymer-Dox Conjugates
Polymer-Paclitaxel Conjugates
Polymer-Camptothecin Conjugates
Polymer-Platinate Conjugates
Segment by Application, the Polymer Drug Conjugates market is segmented into
Cancer Treatment
Leukmia
Hepatitis
Others
Regional and Country-level Analysis
The Polymer Drug Conjugates market is analysed and market size information is provided by regions (countries).
The key regions covered in the Polymer Drug Conjugates market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Polymer Drug Conjugates Market Share Analysis
Polymer Drug Conjugates market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Polymer Drug Conjugates business, the date to enter into the Polymer Drug Conjugates market, Polymer Drug Conjugates product introduction, recent developments, etc.
The major vendors covered:
3S Bio
Abeona Therapeutics
Abramson Cancer Center
Access Pharmaceuticals
Adama
Eyetech
Ferring
Flamel Technologies
Genentech
GlaxoSmithKline
Gowan
Gynecologic Oncology Group Foundation
JenKem Technology
Landec
Lipotek
1 Study Coverage
1.1 Polymer Drug Conjugates Product Introduction
1.2 Market Segments
1.3 Key Polymer Drug Conjugates Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Polymer Drug Conjugates Market Size Growth Rate by Type
1.4.2 Polymer-Dox Conjugates
1.4.3 Polymer-Paclitaxel Conjugates
1.4.4 Polymer-Camptothecin Conjugates
1.4.5 Polymer-Platinate Conjugates
1.5 Market by Application
1.5.1 Global Polymer Drug Conjugates Market Size Growth Rate by Application
1.5.2 Cancer Treatment
1.5.3 Leukmia
1.5.4 Hepatitis
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Polymer Drug Conjugates Market Size, Estimates and Forecasts
2.1.1 Global Polymer Drug Conjugates Revenue 2015-2026
2.1.2 Global Polymer Drug Conjugates Sales 2015-2026
2.2 Global Polymer Drug Conjugates, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Polymer Drug Conjugates Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Polymer Drug Conjugates Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Polymer Drug Conjugates Competitor Landscape by Players
3.1 Polymer Drug Conjugates Sales by Manufacturers
3.1.1 Polymer Drug Conjugates Sales by Manufacturers (2015-2020)
3.1.2 Polymer Drug Conjugates Sales Market Share by Manufacturers (2015-2020)
3.2 Polymer Drug Conjugates Revenue by Manufacturers
3.2.1 Polymer Drug Conjugates Revenue by Manufacturers (2015-2020)
3.2.2 Polymer Drug Conjugates Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Polymer Drug Conjugates Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Polymer Drug Conjugates Revenue in 2019
3.2.5 Global Polymer Drug Conjugates Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Polymer Drug Conjugates Price by Manufacturers
3.4 Polymer Drug Conjugates Manufacturing Base Distribution, Product Types
3.4.1 Polymer Drug Conjugates Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Polymer Drug Conjugates Product Type
3.4.3 Date of International Manufacturers Enter into Polymer Drug Conjugates Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Polymer Drug Conjugates Market Size by Type (2015-2020)
4.1.1 Global Polymer Drug Conjugates Sales by Type (2015-2020)
4.1.2 Global Polymer Drug Conjugates Revenue by Type (2015-2020)
4.1.3 Polymer Drug Conjugates Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Polymer Drug Conjugates Market Size Forecast by Type (2021-2026)
4.2.1 Global Polymer Drug Conjugates Sales Forecast by Type (2021-2026)
4.2.2 Global Polymer Drug Conjugates Revenue Forecast by Type (2021-2026)
4.2.3 Polymer Drug Conjugates Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Polymer Drug Conjugates Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Polymer Drug Conjugates Market Size by Application (2015-2020)
5.1.1 Global Polymer Drug Conjugates Sales by Application (2015-2020)
5.1.2 Global Polymer Drug Conjugates Revenue by Application (2015-2020)
5.1.3 Polymer Drug Conjugates Price by Application (2015-2020)
5.2 Polymer Drug Conjugates Market Size Forecast by Application (2021-2026)
5.2.1 Global Polymer Drug Conjugates Sales Forecast by Application (2021-2026)
5.2.2 Global Polymer Drug Conjugates Revenue Forecast by Application (2021-2026)
5.2.3 Global Polymer Drug Conjugates Price Forecast by Application (2021-2026)
6 North America
6.1 North America Polymer Drug Conjugates by Country
6.1.1 North America Polymer Drug Conjugates Sales by Country
6.1.2 North America Polymer Drug Conjugates Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Polymer Drug Conjugates Market Facts & Figures by Type
6.3 North America Polymer Drug Conjugates Market Facts & Figures by Application
7 Europe
7.1 Europe Polymer Drug Conjugates by Country
7.1.1 Europe Polymer Drug Conjugates Sales by Country
7.1.2 Europe Polymer Drug Conjugates Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Polymer Drug Conjugates Market Facts & Figures by Type
7.3 Europe Polymer Drug Conjugates Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Polymer Drug Conjugates by Region
8.1.1 Asia Pacific Polymer Drug Conjugates Sales by Region
8.1.2 Asia Pacific Polymer Drug Conjugates Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Polymer Drug Conjugates Market Facts & Figures by Type
8.3 Asia Pacific Polymer Drug Conjugates Market Facts & Figures by Application
9 Latin America
9.1 Latin America Polymer Drug Conjugates by Country
9.1.1 Latin America Polymer Drug Conjugates Sales by Country
9.1.2 Latin America Polymer Drug Conjugates Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Polymer Drug Conjugates Market Facts & Figures by Type
9.3 Central & South America Polymer Drug Conjugates Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Polymer Drug Conjugates by Country
10.1.1 Middle East and Africa Polymer Drug Conjugates Sales by Country
10.1.2 Middle East and Africa Polymer Drug Conjugates Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Polymer Drug Conjugates Market Facts & Figures by Type
10.3 Middle East and Africa Polymer Drug Conjugates Market Facts & Figures by Application
11 Company Profiles
11.1 3S Bio
11.1.1 3S Bio Corporation Information
11.1.2 3S Bio Description and Business Overview
11.1.3 3S Bio Sales, Revenue and Gross Margin (2015-2020)
11.1.4 3S Bio Polymer Drug Conjugates Products Offered
11.1.5 3S Bio Related Developments
11.2 Abeona Therapeutics
11.2.1 Abeona Therapeutics Corporation Information
11.2.2 Abeona Therapeutics Description and Business Overview
11.2.3 Abeona Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Abeona Therapeutics Polymer Drug Conjugates Products Offered
11.2.5 Abeona Therapeutics Related Developments
11.3 Abramson Cancer Center
11.3.1 Abramson Cancer Center Corporation Information
11.3.2 Abramson Cancer Center Description and Business Overview
11.3.3 Abramson Cancer Center Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Abramson Cancer Center Polymer Drug Conjugates Products Offered
11.3.5 Abramson Cancer Center Related Developments
11.4 Access Pharmaceuticals
11.4.1 Access Pharmaceuticals Corporation Information
11.4.2 Access Pharmaceuticals Description and Business Overview
11.4.3 Access Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Access Pharmaceuticals Polymer Drug Conjugates Products Offered
11.4.5 Access Pharmaceuticals Related Developments
11.5 Adama
11.5.1 Adama Corporation Information
11.5.2 Adama Description and Business Overview
11.5.3 Adama Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Adama Polymer Drug Conjugates Products Offered
11.5.5 Adama Related Developments
11.6 Eyetech
11.6.1 Eyetech Corporation Information
11.6.2 Eyetech Description and Business Overview
11.6.3 Eyetech Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Eyetech Polymer Drug Conjugates Products Offered
11.6.5 Eyetech Related Developments
11.7 Ferring
11.7.1 Ferring Corporation Information
11.7.2 Ferring Description and Business Overview
11.7.3 Ferring Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Ferring Polymer Drug Conjugates Products Offered
11.7.5 Ferring Related Developments
11.8 Flamel Technologies
11.8.1 Flamel Technologies Corporation Information
11.8.2 Flamel Technologies Description and Business Overview
11.8.3 Flamel Technologies Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Flamel Technologies Polymer Drug Conjugates Products Offered
11.8.5 Flamel Technologies Related Developments
11.9 Genentech
11.9.1 Genentech Corporation Information
11.9.2 Genentech Description and Business Overview
11.9.3 Genentech Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Genentech Polymer Drug Conjugates Products Offered
11.9.5 Genentech Related Developments
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Corporation Information
11.10.2 GlaxoSmithKline Description and Business Overview
11.10.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.10.4 GlaxoSmithKline Polymer Drug Conjugates Products Offered
11.10.5 GlaxoSmithKline Related Developments
11.1 3S Bio
11.1.1 3S Bio Corporation Information
11.1.2 3S Bio Description and Business Overview
11.1.3 3S Bio Sales, Revenue and Gross Margin (2015-2020)
11.1.4 3S Bio Polymer Drug Conjugates Products Offered
11.1.5 3S Bio Related Developments
11.12 Gynecologic Oncology Group Foundation
11.12.1 Gynecologic Oncology Group Foundation Corporation Information
11.12.2 Gynecologic Oncology Group Foundation Description and Business Overview
11.12.3 Gynecologic Oncology Group Foundation Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Gynecologic Oncology Group Foundation Products Offered
11.12.5 Gynecologic Oncology Group Foundation Related Developments
11.13 JenKem Technology
11.13.1 JenKem Technology Corporation Information
11.13.2 JenKem Technology Description and Business Overview
11.13.3 JenKem Technology Sales, Revenue and Gross Margin (2015-2020)
11.13.4 JenKem Technology Products Offered
11.13.5 JenKem Technology Related Developments
11.14 Landec
11.14.1 Landec Corporation Information
11.14.2 Landec Description and Business Overview
11.14.3 Landec Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Landec Products Offered
11.14.5 Landec Related Developments
11.15 Lipotek
11.15.1 Lipotek Corporation Information
11.15.2 Lipotek Description and Business Overview
11.15.3 Lipotek Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Lipotek Products Offered
11.15.5 Lipotek Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Polymer Drug Conjugates Market Estimates and Projections by Region
12.1.1 Global Polymer Drug Conjugates Sales Forecast by Regions 2021-2026
12.1.2 Global Polymer Drug Conjugates Revenue Forecast by Regions 2021-2026
12.2 North America Polymer Drug Conjugates Market Size Forecast (2021-2026)
12.2.1 North America: Polymer Drug Conjugates Sales Forecast (2021-2026)
12.2.2 North America: Polymer Drug Conjugates Revenue Forecast (2021-2026)
12.2.3 North America: Polymer Drug Conjugates Market Size Forecast by Country (2021-2026)
12.3 Europe Polymer Drug Conjugates Market Size Forecast (2021-2026)
12.3.1 Europe: Polymer Drug Conjugates Sales Forecast (2021-2026)
12.3.2 Europe: Polymer Drug Conjugates Revenue Forecast (2021-2026)
12.3.3 Europe: Polymer Drug Conjugates Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Polymer Drug Conjugates Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Polymer Drug Conjugates Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Polymer Drug Conjugates Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Polymer Drug Conjugates Market Size Forecast by Region (2021-2026)
12.5 Latin America Polymer Drug Conjugates Market Size Forecast (2021-2026)
12.5.1 Latin America: Polymer Drug Conjugates Sales Forecast (2021-2026)
12.5.2 Latin America: Polymer Drug Conjugates Revenue Forecast (2021-2026)
12.5.3 Latin America: Polymer Drug Conjugates Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Polymer Drug Conjugates Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Polymer Drug Conjugates Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Polymer Drug Conjugates Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Polymer Drug Conjugates Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Polymer Drug Conjugates Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Polymer Drug Conjugates Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Polymer Drug Conjugates Market Segments
Table 2. Ranking of Global Top Polymer Drug Conjugates Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Polymer Drug Conjugates Market Size Growth Rate by Type 2020-2026 (MG) & (US$ Million)
Table 4. Major Manufacturers of Polymer-Dox Conjugates
Table 5. Major Manufacturers of Polymer-Paclitaxel Conjugates
Table 6. Major Manufacturers of Polymer-Camptothecin Conjugates
Table 7. Major Manufacturers of Polymer-Platinate Conjugates
Table 8. Global Polymer Drug Conjugates Market Size Growth Rate by Application 2020-2026 (MG)
Table 9. Global Polymer Drug Conjugates Market Size by Region (MG) & (US$ Million): 2020 VS 2026
Table 10. Global Polymer Drug Conjugates Sales by Regions 2015-2020 (MG)
Table 11. Global Polymer Drug Conjugates Sales Market Share by Regions (2015-2020)
Table 12. Global Polymer Drug Conjugates Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Polymer Drug Conjugates Sales by Manufacturers (2015-2020) (MG)
Table 14. Global Polymer Drug Conjugates Sales Share by Manufacturers (2015-2020)
Table 15. Global Polymer Drug Conjugates Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Polymer Drug Conjugates by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Polymer Drug Conjugates as of 2019)
Table 17. Polymer Drug Conjugates Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Polymer Drug Conjugates Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Polymer Drug Conjugates Price (2015-2020) (USD/MG)
Table 20. Polymer Drug Conjugates Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Polymer Drug Conjugates Product Type
Table 22. Date of International Manufacturers Enter into Polymer Drug Conjugates Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Polymer Drug Conjugates Sales by Type (2015-2020) (MG)
Table 25. Global Polymer Drug Conjugates Sales Share by Type (2015-2020)
Table 26. Global Polymer Drug Conjugates Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Polymer Drug Conjugates Revenue Share by Type (2015-2020)
Table 28. Polymer Drug Conjugates Average Selling Price (ASP) by Type 2015-2020 (USD/MG)
Table 29. Global Polymer Drug Conjugates Sales by Application (2015-2020) (MG)
Table 30. Global Polymer Drug Conjugates Sales Share by Application (2015-2020)
Table 31. North America Polymer Drug Conjugates Sales by Country (2015-2020) (MG)
Table 32. North America Polymer Drug Conjugates Sales Market Share by Country (2015-2020)
Table 33. North America Polymer Drug Conjugates Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Polymer Drug Conjugates Revenue Market Share by Country (2015-2020)
Table 35. North America Polymer Drug Conjugates Sales by Type (2015-2020) (MG)
Table 36. North America Polymer Drug Conjugates Sales Market Share by Type (2015-2020)
Table 37. North America Polymer Drug Conjugates Sales by Application (2015-2020) (MG)
Table 38. North America Polymer Drug Conjugates Sales Market Share by Application (2015-2020)
Table 39. Europe Polymer Drug Conjugates Sales by Country (2015-2020) (MG)
Table 40. Europe Polymer Drug Conjugates Sales Market Share by Country (2015-2020)
Table 41. Europe Polymer Drug Conjugates Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Polymer Drug Conjugates Revenue Market Share by Country (2015-2020)
Table 43. Europe Polymer Drug Conjugates Sales by Type (2015-2020) (MG)
Table 44. Europe Polymer Drug Conjugates Sales Market Share by Type (2015-2020)
Table 45. Europe Polymer Drug Conjugates Sales by Application (2015-2020) (MG)
Table 46. Europe Polymer Drug Conjugates Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Polymer Drug Conjugates Sales by Region (2015-2020) (MG)
Table 48. Asia Pacific Polymer Drug Conjugates Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Polymer Drug Conjugates Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Polymer Drug Conjugates Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Polymer Drug Conjugates Sales by Type (2015-2020) (MG)
Table 52. Asia Pacific Polymer Drug Conjugates Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Polymer Drug Conjugates Sales by Application (2015-2020) (MG)
Table 54. Asia Pacific Polymer Drug Conjugates Sales Market Share by Application (2015-2020)
Table 55. Latin America Polymer Drug Conjugates Sales by Country (2015-2020) (MG)
Table 56. Latin America Polymer Drug Conjugates Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Polymer Drug Conjugates Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Polymer Drug Conjugates Revenue Market Share by Country (2015-2020)
Table 59. Latin America Polymer Drug Conjugates Sales by Type (2015-2020) (MG)
Table 60. Latin America Polymer Drug Conjugates Sales Market Share by Type (2015-2020)
Table 61. Latin America Polymer Drug Conjugates Sales by Application (2015-2020) (MG)
Table 62. Latin America Polymer Drug Conjugates Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Polymer Drug Conjugates Sales by Country (2015-2020) (MG)
Table 64. Middle East and Africa Polymer Drug Conjugates Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Polymer Drug Conjugates Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Polymer Drug Conjugates Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Polymer Drug Conjugates Sales by Type (2015-2020) (MG)
Table 68. Middle East and Africa Polymer Drug Conjugates Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Polymer Drug Conjugates Sales by Application (2015-2020) (MG)
Table 70. Middle East and Africa Polymer Drug Conjugates Sales Market Share by Application (2015-2020)
Table 71. 3S Bio Corporation Information
Table 72. 3S Bio Description and Major Businesses
Table 73. 3S Bio Polymer Drug Conjugates Production (MG), Revenue (US$ Million), Price (USD/MG) and Gross Margin (2015-2020)
Table 74. 3S Bio Product
Table 75. 3S Bio Recent Development
Table 76. Abeona Therapeutics Corporation Information
Table 77. Abeona Therapeutics Description and Major Businesses
Table 78. Abeona Therapeutics Polymer Drug Conjugates Production (MG), Revenue (US$ Million), Price (USD/MG) and Gross Margin (2015-2020)
Table 79. Abeona Therapeutics Product
Table 80. Abeona Therapeutics Recent Development
Table 81. Abramson Cancer Center Corporation Information
Table 82. Abramson Cancer Center Description and Major Businesses
Table 83. Abramson Cancer Center Polymer Drug Conjugates Production (MG), Revenue (US$ Million), Price (USD/MG) and Gross Margin (2015-2020)
Table 84. Abramson Cancer Center Product
Table 85. Abramson Cancer Center Recent Development
Table 86. Access Pharmaceuticals Corporation Information
Table 87. Access Pharmaceuticals Description and Major Businesses
Table 88. Access Pharmaceuticals Polymer Drug Conjugates Production (MG), Revenue (US$ Million), Price (USD/MG) and Gross Margin (2015-2020)
Table 89. Access Pharmaceuticals Product
Table 90. Access Pharmaceuticals Recent Development
Table 91. Adama Corporation Information
Table 92. Adama Description and Major Businesses
Table 93. Adama Polymer Drug Conjugates Production (MG), Revenue (US$ Million), Price (USD/MG) and Gross Margin (2015-2020)
Table 94. Adama Product
Table 95. Adama Recent Development
Table 96. Eyetech Corporation Information
Table 97. Eyetech Description and Major Businesses
Table 98. Eyetech Polymer Drug Conjugates Production (MG), Revenue (US$ Million), Price (USD/MG) and Gross Margin (2015-2020)
Table 99. Eyetech Product
Table 100. Eyetech Recent Development
Table 101. Ferring Corporation Information
Table 102. Ferring Description and Major Businesses
Table 103. Ferring Polymer Drug Conjugates Production (MG), Revenue (US$ Million), Price (USD/MG) and Gross Margin (2015-2020)
Table 104. Ferring Product
Table 105. Ferring Recent Development
Table 106. Flamel Technologies Corporation Information
Table 107. Flamel Technologies Description and Major Businesses
Table 108. Flamel Technologies Polymer Drug Conjugates Production (MG), Revenue (US$ Million), Price (USD/MG) and Gross Margin (2015-2020)
Table 109. Flamel Technologies Product
Table 110. Flamel Technologies Recent Development
Table 111. Genentech Corporation Information
Table 112. Genentech Description and Major Businesses
Table 113. Genentech Polymer Drug Conjugates Production (MG), Revenue (US$ Million), Price (USD/MG) and Gross Margin (2015-2020)
Table 114. Genentech Product
Table 115. Genentech Recent Development
Table 116. GlaxoSmithKline Corporation Information
Table 117. GlaxoSmithKline Description and Major Businesses
Table 118. GlaxoSmithKline Polymer Drug Conjugates Production (MG), Revenue (US$ Million), Price (USD/MG) and Gross Margin (2015-2020)
Table 119. GlaxoSmithKline Product
Table 120. GlaxoSmithKline Recent Development
Table 121. Gowan Corporation Information
Table 122. Gowan Description and Major Businesses
Table 123. Gowan Polymer Drug Conjugates Sales (MG), Revenue (US$ Million), Price (USD/MG) and Gross Margin (2015-2020)
Table 124. Gowan Product
Table 125. Gowan Recent Development
Table 126. Gynecologic Oncology Group Foundation Corporation Information
Table 127. Gynecologic Oncology Group Foundation Description and Major Businesses
Table 128. Gynecologic Oncology Group Foundation Polymer Drug Conjugates Sales (MG), Revenue (US$ Million), Price (USD/MG) and Gross Margin (2015-2020)
Table 129. Gynecologic Oncology Group Foundation Product
Table 130. Gynecologic Oncology Group Foundation Recent Development
Table 131. JenKem Technology Corporation Information
Table 132. JenKem Technology Description and Major Businesses
Table 133. JenKem Technology Polymer Drug Conjugates Sales (MG), Revenue (US$ Million), Price (USD/MG) and Gross Margin (2015-2020)
Table 134. JenKem Technology Product
Table 135. JenKem Technology Recent Development
Table 136. Landec Corporation Information
Table 137. Landec Description and Major Businesses
Table 138. Landec Polymer Drug Conjugates Sales (MG), Revenue (US$ Million), Price (USD/MG) and Gross Margin (2015-2020)
Table 139. Landec Product
Table 140. Landec Recent Development
Table 141. Lipotek Corporation Information
Table 142. Lipotek Description and Major Businesses
Table 143. Lipotek Polymer Drug Conjugates Sales (MG), Revenue (US$ Million), Price (USD/MG) and Gross Margin (2015-2020)
Table 144. Lipotek Product
Table 145. Lipotek Recent Development
Table 146. Global Polymer Drug Conjugates Sales Forecast by Regions (2021-2026) (MG)
Table 147. Global Polymer Drug Conjugates Sales Market Share Forecast by Regions (2021-2026)
Table 148. Global Polymer Drug Conjugates Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 149. Global Polymer Drug Conjugates Revenue Market Share Forecast by Regions (2021-2026)
Table 150. North America: Polymer Drug Conjugates Sales Forecast by Country (2021-2026) (MG)
Table 151. North America: Polymer Drug Conjugates Revenue Forecast by Country (2021-2026) (US$ Million)
Table 152. Europe: Polymer Drug Conjugates Sales Forecast by Country (2021-2026) (MG)
Table 153. Europe: Polymer Drug Conjugates Revenue Forecast by Country (2021-2026) (US$ Million)
Table 154. Asia Pacific: Polymer Drug Conjugates Sales Forecast by Region (2021-2026) (MG)
Table 155. Asia Pacific: Polymer Drug Conjugates Revenue Forecast by Region (2021-2026) (US$ Million)
Table 156. Latin America: Polymer Drug Conjugates Sales Forecast by Country (2021-2026) (MG)
Table 157. Latin America: Polymer Drug Conjugates Revenue Forecast by Country (2021-2026) (US$ Million)
Table 158. Middle East and Africa: Polymer Drug Conjugates Sales Forecast by Country (2021-2026) (MG)
Table 159. Middle East and Africa: Polymer Drug Conjugates Revenue Forecast by Country (2021-2026) (US$ Million)
Table 160. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 161. Key Challenges
Table 162. Market Risks
Table 163. Main Points Interviewed from Key Polymer Drug Conjugates Players
Table 164. Polymer Drug Conjugates Customers List
Table 165. Polymer Drug Conjugates Distributors List
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Polymer Drug Conjugates Product Picture
Figure 2. Global Polymer Drug Conjugates Sales Market Share by Type in 2020 & 2026
Figure 3. Polymer-Dox Conjugates Product Picture
Figure 4. Polymer-Paclitaxel Conjugates Product Picture
Figure 5. Polymer-Camptothecin Conjugates Product Picture
Figure 6. Polymer-Platinate Conjugates Product Picture
Figure 7. Global Polymer Drug Conjugates Sales Market Share by Application in 2020 & 2026
Figure 8. Cancer Treatment
Figure 9. Leukmia
Figure 10. Hepatitis
Figure 11. Others
Figure 12. Polymer Drug Conjugates Report Years Considered
Figure 13. Global Polymer Drug Conjugates Market Size 2015-2026 (US$ Million)
Figure 14. Global Polymer Drug Conjugates Sales 2015-2026 (MG)
Figure 15. Global Polymer Drug Conjugates Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Polymer Drug Conjugates Sales Market Share by Region (2015-2020)
Figure 17. Global Polymer Drug Conjugates Sales Market Share by Region in 2019
Figure 18. Global Polymer Drug Conjugates Revenue Market Share by Region (2015-2020)
Figure 19. Global Polymer Drug Conjugates Revenue Market Share by Region in 2019
Figure 20. Global Polymer Drug Conjugates Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Polymer Drug Conjugates Revenue in 2019
Figure 22. Polymer Drug Conjugates Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Polymer Drug Conjugates Sales Market Share by Type (2015-2020)
Figure 24. Global Polymer Drug Conjugates Sales Market Share by Type in 2019
Figure 25. Global Polymer Drug Conjugates Revenue Market Share by Type (2015-2020)
Figure 26. Global Polymer Drug Conjugates Revenue Market Share by Type in 2019
Figure 27. Global Polymer Drug Conjugates Market Share by Price Range (2015-2020)
Figure 28. Global Polymer Drug Conjugates Sales Market Share by Application (2015-2020)
Figure 29. Global Polymer Drug Conjugates Sales Market Share by Application in 2019
Figure 30. Global Polymer Drug Conjugates Revenue Market Share by Application (2015-2020)
Figure 31. Global Polymer Drug Conjugates Revenue Market Share by Application in 2019
Figure 32. North America Polymer Drug Conjugates Sales Growth Rate 2015-2020 (MG)
Figure 33. North America Polymer Drug Conjugates Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Polymer Drug Conjugates Sales Market Share by Country in 2019
Figure 35. North America Polymer Drug Conjugates Revenue Market Share by Country in 2019
Figure 36. U.S. Polymer Drug Conjugates Sales Growth Rate (2015-2020) (MG)
Figure 37. U.S. Polymer Drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Polymer Drug Conjugates Sales Growth Rate (2015-2020) (MG)
Figure 39. Canada Polymer Drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Polymer Drug Conjugates Market Share by Type in 2019
Figure 41. North America Polymer Drug Conjugates Market Share by Application in 2019
Figure 42. Europe Polymer Drug Conjugates Sales Growth Rate 2015-2020 (MG)
Figure 43. Europe Polymer Drug Conjugates Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Polymer Drug Conjugates Sales Market Share by Country in 2019
Figure 45. Europe Polymer Drug Conjugates Revenue Market Share by Country in 2019
Figure 46. Germany Polymer Drug Conjugates Sales Growth Rate (2015-2020) (MG)
Figure 47. Germany Polymer Drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Polymer Drug Conjugates Sales Growth Rate (2015-2020) (MG)
Figure 49. France Polymer Drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Polymer Drug Conjugates Sales Growth Rate (2015-2020) (MG)
Figure 51. U.K. Polymer Drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Polymer Drug Conjugates Sales Growth Rate (2015-2020) (MG)
Figure 53. Italy Polymer Drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Polymer Drug Conjugates Sales Growth Rate (2015-2020) (MG)
Figure 55. Russia Polymer Drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Polymer Drug Conjugates Market Share by Type in 2019
Figure 57. Europe Polymer Drug Conjugates Market Share by Application in 2019
Figure 58. Asia Pacific Polymer Drug Conjugates Sales Growth Rate 2015-2020 (MG)
Figure 59. Asia Pacific Polymer Drug Conjugates Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Polymer Drug Conjugates Sales Market Share by Region in 2019
Figure 61. Asia Pacific Polymer Drug Conjugates Revenue Market Share by Region in 2019
Figure 62. China Polymer Drug Conjugates Sales Growth Rate (2015-2020) (MG)
Figure 63. China Polymer Drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Polymer Drug Conjugates Sales Growth Rate (2015-2020) (MG)
Figure 65. Japan Polymer Drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Polymer Drug Conjugates Sales Growth Rate (2015-2020) (MG)
Figure 67. South Korea Polymer Drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Polymer Drug Conjugates Sales Growth Rate (2015-2020) (MG)
Figure 69. India Polymer Drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Polymer Drug Conjugates Sales Growth Rate (2015-2020) (MG)
Figure 71. Australia Polymer Drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Polymer Drug Conjugates Sales Growth Rate (2015-2020) (MG)
Figure 73. Taiwan Polymer Drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Polymer Drug Conjugates Sales Growth Rate (2015-2020) (MG)
Figure 75. Indonesia Polymer Drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Polymer Drug Conjugates Sales Growth Rate (2015-2020) (MG)
Figure 77. Thailand Polymer Drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Polymer Drug Conjugates Sales Growth Rate (2015-2020) (MG)
Figure 79. Malaysia Polymer Drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Polymer Drug Conjugates Sales Growth Rate (2015-2020) (MG)
Figure 81. Philippines Polymer Drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Polymer Drug Conjugates Sales Growth Rate (2015-2020) (MG)
Figure 83. Vietnam Polymer Drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Polymer Drug Conjugates Market Share by Type in 2019
Figure 85. Asia Pacific Polymer Drug Conjugates Market Share by Application in 2019
Figure 86. Latin America Polymer Drug Conjugates Sales Growth Rate 2015-2020 (MG)
Figure 87. Latin America Polymer Drug Conjugates Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Polymer Drug Conjugates Sales Market Share by Country in 2019
Figure 89. Latin America Polymer Drug Conjugates Revenue Market Share by Country in 2019
Figure 90. Mexico Polymer Drug Conjugates Sales Growth Rate (2015-2020) (MG)
Figure 91. Mexico Polymer Drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Polymer Drug Conjugates Sales Growth Rate (2015-2020) (MG)
Figure 93. Brazil Polymer Drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Polymer Drug Conjugates Sales Growth Rate (2015-2020) (MG)
Figure 95. Argentina Polymer Drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Polymer Drug Conjugates Market Share by Type in 2019
Figure 97. Latin America Polymer Drug Conjugates Market Share by Application in 2019
Figure 98. Middle East and Africa Polymer Drug Conjugates Sales Growth Rate 2015-2020 (MG)
Figure 99. Middle East and Africa Polymer Drug Conjugates Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Polymer Drug Conjugates Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Polymer Drug Conjugates Revenue Market Share by Country in 2019
Figure 102. Turkey Polymer Drug Conjugates Sales Growth Rate (2015-2020) (MG)
Figure 103. Turkey Polymer Drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Polymer Drug Conjugates Sales Growth Rate (2015-2020) (MG)
Figure 105. Saudi Arabia Polymer Drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Polymer Drug Conjugates Sales Growth Rate (2015-2020) (MG)
Figure 107. U.A.E Polymer Drug Conjugates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Polymer Drug Conjugates Market Share by Type in 2019
Figure 109. Middle East and Africa Polymer Drug Conjugates Market Share by Application in 2019
Figure 110. North America Polymer Drug Conjugates Sales Growth Rate Forecast (2021-2026) (MG)
Figure 111. North America Polymer Drug Conjugates Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Polymer Drug Conjugates Sales Growth Rate Forecast (2021-2026) (MG)
Figure 113. Europe Polymer Drug Conjugates Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Polymer Drug Conjugates Sales Growth Rate Forecast (2021-2026) (MG)
Figure 115. Asia Pacific Polymer Drug Conjugates Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Polymer Drug Conjugates Sales Growth Rate Forecast (2021-2026) (MG)
Figure 117. Latin America Polymer Drug Conjugates Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Polymer Drug Conjugates Sales Growth Rate Forecast (2021-2026) (MG)
Figure 119. Middle East and Africa Polymer Drug Conjugates Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
抗体薬物複合体（ADC）の世界市場（～2026年） Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased…- フィコビリタンパク質コンジュゲートの世界市場（～2026年） Phycobiliproteins are water-soluble proteins present in cyanobacteria and certain algae which capture light energy, which is then passed on to chlorophylls during photosynthesis. Phycobiliprotein conjugates can be applied to fluorescence-activated cell sorting and analysis, fluorescence microscopy a…
- ドラッグデリバリーポリマー用接着剤ソリューションの世界市場（～2026年） Transdermal drug delivery system are topically administered medicaments in the form of patches that deliver drugs for systemic effects at a predetermined and controlled rate. An adhesive solution for drug delivery polymer, which is a customize solution to fit drug formulation needs using a variety o…
- インテリジェントポリマーの世界市場（～2026年） Intelligent Polymer is high-performance polymers that change according to the environment they are in. Such materials can be sensitive to a number of factors, such as temperature, humidity, pH, the wavelength or intensity of light or an electrical or magnetic field and can respond in various ways, l…
- ソリッドステート・ポリマーバッテリーの世界市場（～2026年） Solid state battery is an advanced type of battery which uses solid electrolytes along with solid electrodes instead of the liquid electrolytes and polymer electrolytes found in traditional lithium ion and lithium polymer batteries. The solid state and polymer batteries offers several advantages ove…